Large-scale testing (Phase 3)Active Not RecruitingNCT04708041
What this trial is testing
Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)
Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 700